Reducing Depressive Symptoms through AI-Guided Narrative Self-Films: A Formative Randomized Controlled Trial
Journal of Technology in Behavioral Science · 05.03.2026
DOI: 10.1007/s41347-026-00596-5 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Technology in Behavioral Science, online erschienen am 05.03.2026. Verfasst von Elvin Yao und 1 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hong Kong University of Science and Technology.
Themen: Depression
Abstract (Originalsprache)
Depression remains a leading global health concern, yet theory-based applications of generative artificial intelligence (AI) to mental-health support have received little empirical scrutiny. The present study tested a five-day, AI-assisted “self-film” intervention grounded in narrative-identity theory. In a 3 (value framing: independent, interdependent, neutral) × 2 (narrative arc: ideal-only, conflict-resolution) factorial randomized controlled trial, 181 Chinese undergraduates with mild-to-moderate depressive symptoms produced short AI-generated videos depicting their past, present, and future selves and then compiled them into personalised self-films. Depression, state hope, narrative coherence, and future self-continuity were measured before and after the programme. Conflict-resolution storytelling reduced depressive symptoms on the PHQ-9 compared with ideal-only conditions; the strongest decline occurred in the interdependent/conflict-resolution group. Conflict-resolution participants also recorded significant gains in hope, narrative coherence, and self-continuity. These results provide preliminary evidence that a brief, culturally attuned, AI-supported storytelling exercise can enhance multiple indices of psychological well-being, suggesting promise for scalable digital interventions beyond traditional clinical settings.Depression remains a leading global health concern, yet theory-based applications of generative artificial intelligence (AI) To mental-health support Have Received Little Empirical scrutiny. The Present Study Tested a five-day, AI-assisted “self-film” Intervention Grounded in Narrative-identity theory. In a 3 (value Framing: independent, interdependent, neutral) × 2 (narrative Arc: ideal-only, conflict-resolution) Factorial Randomized Controlled trial, 181 Chinese Undergraduates with mild-to-moderate Depressive Symptoms Produced Short AI-generated Videos Depicting their past, Present, and Future Selves and Then Compiled Them into Personalized self-films. Depression, State hope, Narrative coherence, and Future self-continuity Were Measured before and after the Study. Conflict-resolution Storytelling Reduced Depressive Symptoms on the PHQ-9 Compared with ideal-only conditions; the Strongest Decline Occurred in the interdependent/conflict-resolution group. Conflict-resolution Participants Also Recorded Significant Gains in hope, Narrative coherence, and self-continuity. These Results Provide Preliminary Evidence that a brief, Culturally attuned, AI-supported Storytelling Exercise Can Enhance Multiple Indices of Psychological well-being, Suggesting Promise for Scalable Digital Interventions Beyond Traditional Clinical Settings.
Förderung
- Hong Kong University of Science and Technology
Zitieren
APA
Yao, E., & Yang, H. (2026). Reducing Depressive Symptoms through AI-Guided Narrative Self-Films: A Formative Randomized Controlled Trial. Journal of Technology in Behavioral Science. https://doi.org/10.1007/s41347-026-00596-5
Vancouver
Yao E, Yang H. Reducing Depressive Symptoms through AI-Guided Narrative Self-Films: A Formative Randomized Controlled Trial. Journal of Technology in Behavioral Science. 2026. doi:10.1007/s41347-026-00596-5
BibTeX
@article{Yao2026,
author = {Yao, Elvin and Yang, Harry},
title = {Reducing Depressive Symptoms through AI-Guided Narrative Self-Films: A Formative Randomized Controlled Trial},
journal = {Journal of Technology in Behavioral Science},
year = {2026},
doi = {10.1007/s41347-026-00596-5}
}
EUVIMED